Stay updated on Dolatav Clinical Trial: Nucleoside Sparing in HIV-1
Sign up to get notified when there's something new on the Dolatav Clinical Trial: Nucleoside Sparing in HIV-1 page.

Latest updates to the Dolatav Clinical Trial: Nucleoside Sparing in HIV-1 page
- Check3 days agoChange DetectedThis update adds Revision: v3.6.3 and removes Revision: v3.6.2. It reflects a metadata-level release with no changes to the study data or front‑end content.SummaryDifference0.1%

- Check10 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.2, indicating a backend versioning update. The user-facing content and layout remain unchanged.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check25 days agoChange DetectedRecruitment status was updated to 'no longer looking for participants,' clarifying that enrollment is closed. The page also adds a How to Join a Study section and minor navigational/header updates (How to Read a Study Record, Common Questions), with a formatting/metadata change to the Interventions heading and a revision note.SummaryDifference0.5%

- Check32 days agoChange DetectedThe revision history for the study record was updated from v3.5.4 to v3.5.5, representing a small update to the page documentation. This change does not alter study details, eligibility criteria, or reported results.SummaryDifference0.1%

- Check53 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4 on the study record page. This represents a minor metadata/version update rather than a substantive change to study details.SummaryDifference0.1%

- Check74 days agoChange DetectedThis update advances the site’s displayed revision version in the page footer (v3.5.2 → v3.5.3) without altering the study record details.SummaryDifference0.1%

Stay in the know with updates to Dolatav Clinical Trial: Nucleoside Sparing in HIV-1
Enter your email address, and we'll notify you when there's something new on the Dolatav Clinical Trial: Nucleoside Sparing in HIV-1 page.